 |
 |
| The SpectraWAVE acquisition will expand Philips’ existing intravascular imaging and physiological assessment device portfolio, with a dual optical imaging technique combining OCT and NIRS to investigate both the shape and biochemical nature of arterial plaques - providing an extra level of insight and, it is hoped, improved patient outcomes. Image: SpectraWAVE. |
| © 2025 SPIE Europe |
|
